[HTML][HTML] Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
T Shiroyama, I Nagatomo, S Koyama, H Hirata… - Scientific reports, 2019 - nature.com
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors
T Shiroyama, A Kumanogoh - crcast.osaka-u.ac.jp
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We evaluated all patients treated with nivolumab or …
programmed death (PD)-1 inhibitors. We evaluated all patients treated with nivolumab or …
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors
T Shiroyama, A Kumanogoh - uic.osaka-u.ac.jp
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We evaluated all patients treated with nivolumab or …
programmed death (PD)-1 inhibitors. We evaluated all patients treated with nivolumab or …
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
T Shiroyama, I Nagatomo, S Koyama… - Scientific …, 2019 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors
T Shiroyama, A Kumanogoh - ccb.osaka-u.ac.jp
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We evaluated all patients treated with nivolumab or …
programmed death (PD)-1 inhibitors. We evaluated all patients treated with nivolumab or …
Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
T Shiroyama, I Nagatomo, S Koyama, H Hirata… - Scientific Reports, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The aim of this study was to investigate the
clinical impact of sarcopenia on the efficacy of programmed death (PD)-1 inhibitors. We …
clinical impact of sarcopenia on the efficacy of programmed death (PD)-1 inhibitors. We …
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.
T Shiroyama, I Nagatomo, S Koyama… - Scientific …, 2019 - search.ebscohost.com
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors
T Shiroyama, I Nagatomo, S Koyama, H Hirata… - Scientific Reports - ifrec.osaka-u.ac.jp
Takayuki Shiroyama (Oncology Center of Osaka University Hospital), Atsushi Kumanogoh
(Graduate School of Medicine, Osaka University/IFReC) and the research group …
(Graduate School of Medicine, Osaka University/IFReC) and the research group …
[HTML][HTML] Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
T Shiroyama, I Nagatomo, S Koyama, H Hirata… - Scientific …, 2019 - ncbi.nlm.nih.gov
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study.
T Shiroyama, I Nagatomo, S Koyama, H Hirata… - Scientific …, 2019 - europepmc.org
The aim of this study was to investigate the clinical impact of sarcopenia on the efficacy of
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …
programmed death (PD)-1 inhibitors. We retrospectively reviewed the medical records of all …